Comparison of Patient-Reported Outcomes During Treatment With Adjustable- and Fixed-Dose Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Fixed-Dose Fluticasone Propionate/Salmeterol Dry Powder Inhaler in Patients With Asthma

References

• Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda, MD: National Heart, Lung, and Blood Institute; 2006. NIH Publication No. 02-3659.
   Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007. NIH Publication No. 07-4051.
   Google Scholar
• Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. J Allergy Clin Immunol 2008; 121:1407–1414, e1401–1406.
   PubMed Web of Science ®Google Scholar
• Marquis P, Trudeau E. Quality of life and patient satisfaction: Two important aspects in asthma therapy. Curr Opin Pulm Med 2001; 7(suppl 1):S18–S20.
   PubMedGoogle Scholar
• Smith NA, Ley P, Seale JP, Shaw J. Health beliefs, satisfaction and compliance. Patient Educ Couns 1987; 10:279–286.
   PubMed Web of Science ®Google Scholar
• Osman LM. How do patients' views about medication affect their self-management in asthma? Patient Educ Couns 1997; 32:S43–S49.
   PubMed Web of Science ®Google Scholar
• Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55:566–573.
   PubMed Web of Science ®Google Scholar
• Morice AH, Peterson S, Beckman O, Osmanliev D. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract 2007; 61:1874–1883.
   PubMed Web of Science ®Google Scholar
• Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O’Dowd L. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Ann Allergy Asthma Immunol 2008; 101:463–473.
   PubMed Web of Science ®Google Scholar
• Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O’Dowd L. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Curr Med Res Opin 2008; 24:879–894.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999; 115:1265–1270.
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902–907.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99:553–558.
   PubMed Web of Science ®Google Scholar
• Martin ML, Patrick DL, Bushnell DM, Meltzer EO, Gutierrez B, Parasuraman B. The Asthma Treatment Satisfaction Measure (ATSM) for patients with asthma. Curr Med Res Opin 2009; 25:2495–2506.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Martin ML, Bushnell DM, Pesa J. Measuring satisfaction with migraine treatment: Expectations, importance, outcomes, and global ratings. Clin Ther 2003; 25:2920–2935.
   PubMed Web of Science ®Google Scholar
• Martin ML, Patrick DL, Bushnell DM, Gandra SR, Gilchrist K. Further validation of an individualized migraine treatment satisfaction measure. Value Health 2008; 11:904–912.
   PubMed Web of Science ®Google Scholar
• Leidy NK, Mathias SD, Parasuraman BM, Patrick DL, Pathak D. Development and validation of an onset of effect questionnaire for patients with asthma. Allergy Asthma Proc 2008; 29:590–599.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994; 47:81–87.
   PubMed Web of Science ®Google Scholar
• Buhl R, Kardos P, Richter K, Meyer-Sabellek W, Bruggenjurgen B, Willich SN, Vogelmeier C. The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing. Curr Med Res Opin 2004; 20:1209–1220.
   PubMed Web of Science ®Google Scholar
• Smith JR, Mildenhall S, Noble M, Mugford M, Shepstone L, Harrison BD. Clinician-assessed poor compliance identifies adults with severe asthma who are at risk of adverse outcomes. J Asthma 2005; 42:437–445.
   PubMed Web of Science ®Google Scholar
• Hampel FC, Martin P, Mezzanotte WS. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. J Asthma 2008; 45:265–272.
   PubMed Web of Science ®Google Scholar
• Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lotvall J. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 2001; 14:29–34.
   PubMed Web of Science ®Google Scholar
• Van Der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther 2004; 17:89–95.
   PubMed Web of Science ®Google Scholar
• Palmqvist M, Persson G, Lazer L, Rosenborg J, Larsson P, Lotvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency. Eur Respir J 1997; 10:2484–2489.
   PubMed Web of Science ®Google Scholar
• Bender BG, Long A, Parasuraman B, Tran ZV. Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol 2007; 98:322–328.
   PubMed Web of Science ®Google Scholar
• Hauber AB, Mohamed AF, Johnson FR, Meddis D, Wagner S, O’Dowd L. Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications. Allergy Asthma Proc 2009; 30:139–147.
   PubMed Web of Science ®Google Scholar